Cloud-clone
SKU(재고 관리 코드):MAF757Hu21
Monoclonal Antibody to Peroxiredoxin 2 (PRDX2)
Monoclonal Antibody to Peroxiredoxin 2 (PRDX2)
Western blotting: 0.5-2µg/mL
;Immunohistochemistry: 5-20µg/mL
;Immunocytochemistry: 5-20µg/mL
;Optimal working dilutions must be determined by end user.
Product No.
MAF757Hu21
Organism Species
Homo sapiens (Human).
Source
Monoclonal antibody preparation
Host
Mouse
Potency (Clone Number)
C2
Ig Isotype
IgG1 Kappa
Purification
Protein A + Protein G affinity chromatography
Label
None
Immunogen
RPF757Hu03-Recombinant Peroxiredoxin 2 (PRDX2)
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Traits
Liquid
Concentration
1mg/ml
Organism Species More
Rattus norvegicus (Rat)
Applications
WB
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a mouse monoclonal antibody raised against PRDX2. It has been selected for its ability to recognize PRDX2 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.01-2µg/mL
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Free Radical Research | Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress Pubmed:25564095 |
| PLoS One | Differences in Proinflammatory Property of Six Subtypes of Peroxiredoxins and Anti-Inflammatory Effect of Ligustilide in Macrophages pubmed:27716839 |
| Experiental And Therapeutic Medicine | Plasma proteins as potential targets of abnormal Savda syndrome in asthma patients treated with unique Uighur prescription pubmed:28672924 |
| Oncotarget | Neuroprotective effect of a novel gastrodin derivative against ischemic brain injury: involvement of peroxiredoxin and TLR4 signaling inhibition pubmed:29207618 |
| European Journal of Applied Physiology | Prolonged forearm ischemia attenuates endothelium-dependent vasodilatation and plasma nitric oxide metabolites in overweight middle-aged men Pubmed:29785503 |
| Journal of Applied Physiology | Montmorency cherry supplementation attenuates vascular dysfunction induced by prolonged forearm occlusion in overweight middle-aged men Pubmed: 30496705 |
| ACS Omega | SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics 34250342 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPF757Hu02 | Recombinant Peroxiredoxin 2 (PRDX2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPF757Hu03 | Recombinant Peroxiredoxin 2 (PRDX2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPF757Hu01 | Recombinant Peroxiredoxin 2 (PRDX2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAF757Hu01 | Polyclonal Antibody to Peroxiredoxin 2 (PRDX2) | WB; IHC; ICC; IP. |
| PAF757Hu03 | Polyclonal Antibody to Peroxiredoxin 2 (PRDX2) | WB; IHC; ICC; IP. |
| PAF757Hu02 | Polyclonal Antibody to Peroxiredoxin 2 (PRDX2) | WB; IHC; ICC; IP. |
| MAF757Hu23 | Monoclonal Antibody to Peroxiredoxin 2 (PRDX2) | WB; IHC; ICC; IP. |
| MAF757Hu21 | Monoclonal Antibody to Peroxiredoxin 2 (PRDX2) | WB |
| WEF757Hu | Wide-range ELISA Kit for Peroxiredoxin 2 (PRDX2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEF757Hu | ELISA Kit for Peroxiredoxin 2 (PRDX2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMF757Hu | Magnetic Luminex Assay Kit for Peroxiredoxin 2 (PRDX2) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
